{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+1&page=2", "query": { "intervention": "Part 1", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+1&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-25T13:34:29.269Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04478708", "title": "Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "maridebart cafraglutide", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 110, "start_date": "2020-08-07", "completion_date": "2022-11-18", "has_results": true, "last_update_posted_date": "2025-12-10", "last_synced_at": "2026-09-25T13:34:29.269Z", "location_count": 3, "location_summary": "Anaheim, California • Tustin, California • Miami, Florida", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Tustin", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04478708" }, { "nct_id": "NCT02723955", "title": "Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neoplasms" ], "interventions": [ { "name": "feladilimab (GSK3359609)", "type": "DRUG" }, { "name": "GSK3174998", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" }, { "name": "Paclitaxel plus Carboplatin", "type": "DRUG" }, { "name": "Gemcitabine plus Carboplatin", "type": "DRUG" }, { "name": "Fluorouracil (5-FU) plus carboplatin or cisplatin", "type": "DRUG" }, { "name": "Dostarlimab", "type": "DRUG" }, { "name": "Cobolimab", "type": "DRUG" }, { "name": "Bintrafusp alfa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "93 Years", "sex": "ALL", "summary": "18 Years to 93 Years" }, "enrollment_count": 829, "start_date": "2016-06-23", "completion_date": "2023-07-05", "has_results": true, "last_update_posted_date": "2024-12-27", "last_synced_at": "2026-09-25T13:34:29.269Z", "location_count": 9, "location_summary": "Duarte, California • Los Angeles, California • Sarasota, Florida + 4 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sarasota", "state": "Florida" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02723955" }, { "nct_id": "NCT01906385", "title": "Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Glioma" ], "interventions": [ { "name": "Rhenium Liposome Treatment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cerenome", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 55, "start_date": "2015-06-03", "completion_date": "2025-12", "has_results": false, "last_update_posted_date": "2025-03-26", "last_synced_at": "2026-09-25T13:34:29.269Z", "location_count": 3, "location_summary": "Manhasset, New York • Dallas, Texas • San Antonio, Texas", "locations": [ { "city": "Manhasset", "state": "New York" }, { "city": "Dallas", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01906385" }, { "nct_id": "NCT00090415", "title": "Early Characteristics of Autism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Autism", "Autistic Disorder" ], "interventions": [ { "name": "Intensive behavioral therapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Months", "maximum_age": "30 Months", "sex": "ALL", "summary": "18 Months to 30 Months" }, "enrollment_count": 48, "start_date": "2003-04", "completion_date": null, "has_results": false, "last_update_posted_date": "2012-06-19", "last_synced_at": "2026-09-25T13:34:29.269Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00090415" }, { "nct_id": "NCT03064906", "title": "Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "Insulet AP (artificial pancreas) System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Insulet Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 24, "start_date": "2017-03-18", "completion_date": "2017-04-07", "has_results": false, "last_update_posted_date": "2018-06-12", "last_synced_at": "2026-09-25T13:34:29.269Z", "location_count": 3, "location_summary": "Palo Alto, California • Walnut Creek, California • Denver, Colorado", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03064906" }, { "nct_id": "NCT03758638", "title": "Healthy Eating and Active Living Taught at Home (HEALTH) Dissemination & Implementation (D&I)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "Healthy Eating & Active Living Taught at Home", "type": "BEHAVIORAL" }, { "name": "Usual Care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 620, "start_date": "2019-01-25", "completion_date": "2025-06-30", "has_results": true, "last_update_posted_date": "2025-11-12", "last_synced_at": "2026-09-25T13:34:29.269Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03758638" }, { "nct_id": "NCT06567015", "title": "Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Non-small Cell Lung Cancer (NSCLC)" ], "interventions": [ { "name": "STX-241", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pierre Fabre Medicament", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 171, "start_date": "2024-09-17", "completion_date": "2030-07", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-09-25T13:34:29.269Z", "location_count": 2, "location_summary": "Nashville, Tennessee • Houston, Texas", "locations": [ { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06567015" }, { "nct_id": "NCT04742634", "title": "Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Myelodysplastic Syndromes" ], "interventions": [ { "name": "DEC-C", "type": "DRUG" }, { "name": "MyeloSeq-HD", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 209, "start_date": "2022-05-12", "completion_date": "2033-11-30", "has_results": false, "last_update_posted_date": "2026-03-23", "last_synced_at": "2026-09-25T13:34:29.269Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04742634" }, { "nct_id": "NCT03355209", "title": "A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lennox Gastaut Syndrome" ], "interventions": [ { "name": "ZX008 0.2 or 0.8 mg/kg/day", "type": "DRUG" }, { "name": "Matching Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "2 Years to 35 Years" }, "enrollment_count": 296, "start_date": "2017-11-27", "completion_date": "2024-05-23", "has_results": true, "last_update_posted_date": "2025-07-03", "last_synced_at": "2026-09-25T13:34:29.269Z", "location_count": 30, "location_summary": "Tucson, Arizona • Los Angeles, California • San Francisco, California + 26 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03355209" }, { "nct_id": "NCT03127709", "title": "A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Histiocytosis" ], "interventions": [ { "name": "Trail Making Test, Parts A & B", "type": "BEHAVIORAL" }, { "name": "Brief Test of Attention", "type": "BEHAVIORAL" }, { "name": "Symbol Span", "type": "BEHAVIORAL" }, { "name": "Controlled Oral Word Association Test", "type": "BEHAVIORAL" }, { "name": "The Hopkins Verbal Learning Test-Revised", "type": "BEHAVIORAL" }, { "name": "Brief Visuospatial Memory Test-Revised", "type": "BEHAVIORAL" }, { "name": "Hospital Anxiety and Depression Scale", "type": "BEHAVIORAL" }, { "name": "McGill Quality of Life Scale", "type": "BEHAVIORAL" }, { "name": "MR Brain Imaging", "type": "DIAGNOSTIC_TEST" }, { "name": "Resting state functional MRI", "type": "DIAGNOSTIC_TEST" }, { "name": "Functional Assessment of Cancer Therapy Cognitive Scale (FACT-Cog)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL", "DIAGNOSTIC_TEST" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 13, "start_date": "2017-04-07", "completion_date": "2027-04", "has_results": false, "last_update_posted_date": "2026-05-07", "last_synced_at": "2026-09-25T13:34:29.269Z", "location_count": 4, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Commack, New York + 1 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03127709" } ] }